Lip Diseases: Clinical Trials

14 trials for Lip Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 14 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 114Completed 10, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 28Completed 5, Not yet recruiting 1, Recruiting 1, Unknown 1

Follow Lip Diseases: new trials by email Literature Review of Lip Diseases trials Research Report on Lip Diseases

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)
Hypofractionated Stereotactic Body Radiotherapy (SBRT), Pembrolizumab, Ficerafusp alfa - Head and Neck Squamous Cell Carcinoma, HPV-Negative Squamous Cell Carcinoma
Phase 1 / Phase 2Not yet recruitingWashington University School of Medicine452026-11-302026-11-03
Evaluation of Nasal Elevator Versus Grayson's Nasal Stent with D-NAM Appliance on Nasolabial Esthetics in Bilateral Cleft Lip and Palate Infants
Nasal elevator with digital nasoalveolar molding in bilateral cleft lip and palate infants, Nasal stent with digital nasoalveolar molding in bilateral cleft lip and palate infants - Cleft Lip and Cleft Palate
Phase 1UnknownCairo University202024-11-012024-10-17
Phase I-IIa, to Evaluate the Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Cleft Palate.
implantation with an autologous human palatal mucosa substitute made of nanostructured fibrin-agarose generated by tissue engineering (BIOCLEFT). - Cleft Lip and Palate
Phase 1 / Phase 2RecruitingElisa María Cubiles Montero de Espinosa152024-04-172024-05-10
Comparison Between Low Level Laser Therapy and Active Oxygen Releasing Gel on Wound Healing Cleft Lip Patients
biolase laser, blue m gel - Cleft Lip
Phase 1CompletedFaculty of Dental Medicine for Girls152022-08-202025-01-09
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
A166 - HER2-positive Breast Cancer, HER2 Gene Mutation
Phase 1 / Phase 2CompletedKlus Pharma Inc.492018-07-162023-08-03
Effectiveness and Clinical Mechanism of Huanglian-Jiedu Decoction in Patients With Intense-exuberant Stomach Fire Syndrome
Huanglian-Jiedu Decoction - Intense-exuberant Stomach Fire Syndrom, Acute Pericoronitis
Phase 1 / Phase 2UnknownChina Academy of Chinese Medical Sciences2402018-04-042018-04-10
Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1)
Squaric Acid Dibutyl Ester - HSV, Herpes Labialis
Phase 1CompletedSquarex, LLC362017-03-022021-11-03
Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis
SADBE, Placebo - Herpes Labialis, Cold Sore
Phase 1 / Phase 2CompletedSquarex, LLC1392016-12-012021-11-02
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair
Botulinum Toxin Type A, Normal Saline Injection - Cleft Lip, Scarring
Phase 1 / Phase 2CompletedThe University of Texas Health Science Center, Houston302015-12-012021-11-03
Description of Pain in Pediatric Patients With Cleft Lip and Palate Undergoing Alveolar Grafting Using Two Surgical Strategies: Stem Cells and Autogenous Iliac Crest Bone (Pain Evaluation in Children Undergoing Alveolar Grafting: Stem Cells vs. Iliac Crest Bone)
Autogenous Iliac Crest Bone Grafting, Bioengineered Alveolar Grafting (SHED + Scaffold) - Clift Lip, Cleft Palate
Phase 1 / Phase 2CompletedHospital Sirio-Libanes202015-03-012026-07-29
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
Squaric Acid solution, Placebo solution - Herpes Labialis
Phase 1CompletedMassachusetts General Hospital542013-10-012017-10-02
An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode
Acyclovir patch, Placebo patch - Herpes Labialis
Phase 1CompletedGlaxoSmithKline602012-07-012014-07-16
Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
BTL TML HSV, Matching placebo - Oral Herpes Simplex
Phase 1 / Phase 2CompletedBeech Tree Labs, Inc.1712011-01-012013-08-13
Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers
New formulation, Current formulation - Herpes Labialis
Phase 1CompletedGlaxoSmithKline272008-04-102018-08-31

Narrower conditions

Herpes Labialis (7)  ·  Cleft Lip (5)  ·  Cleft Palate (3)  ·  Cicatrix (2)  ·  Head and Neck Neoplasms (2)  ·  Laryngeal Neoplasms (2)  ·  Lip Neoplasms (2)  ·  Mouth Neoplasms (2)  ·  Tongue Neoplasms (2)  ·  Alveolar Bone Loss (1)  ·  Bile Duct Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Mucoepidermoid (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Squamous Cell (1)

Broader conditions

Mouth Diseases (14)  ·  Stomatognathic Diseases (14)  ·  Skin Diseases (8)  ·  Skin and Connective Tissue Diseases (8)  ·  DNA Virus Infections (7)  ·  Herpesviridae Infections (7)  ·  Infections (7)  ·  Skin Diseases, Infectious (7)  ·  Skin Diseases, Viral (7)  ·  Virus Diseases (7)  ·  Herpes Simplex (6)  ·  Congenital Abnormalities (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Mouth Abnormalities (5)

Interventions

squaric acid dibutyl ester (3)  ·  Botulinum Toxins, Type A (1)  ·  Drug Implants (1)  ·  Saline Solution (1)  ·  huanglian-jie-du decoction (1)  ·  pembrolizumab (1)

Sponsors

GlaxoSmithKline (2)  ·  Squarex, LLC (2)  ·  Beech Tree Labs, Inc. (1)  ·  Cairo University (1)  ·  China Academy of Chinese Medical Sciences (1)  ·  Elisa María Cubiles Montero de Espinosa (1)  ·  Faculty of Dental Medicine for Girls (1)  ·  Hospital Sirio-Libanes (1)  ·  Klus Pharma Inc. (1)  ·  Massachusetts General Hospital (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  Washington University School of Medicine (1)

Countries

United States (7)  ·  Brazil (1)  ·  China (1)  ·  Egypt (1)  ·  Germany (1)  ·  Japan (1)  ·  Spain (1)

Top investigators

Alexandra B Kimball, MD (1)  ·  Hugh McTavish, PhD, JD (1)  ·  Jaecel O Shah, MD (1)  ·  Jordi Rodon Ahnert, MD, PhD (1)  ·  Mark Matson, MD (1)  ·  Mohsena Ahmed (1)  ·  Sana Karam, MD, PhD (1)  ·  Sidharth Puram, MD, PhD (1)  ·  Thomas D Horn, MD (1)  ·  Zhong Wang (1)

Results publications

PMID 30756512, PMID 33913104, PMID 35142535, PMID 39638596